NEW YORK (360Dx) – Siemens Healthineers today announced a definitive agreement to acquire Epocal, an Alere subsidiary developing point-of-care blood diagnostic systems.

Alere said in a document filed with the US Securites and Exchange Commission that it is selling Epocal in connection with a review by the US Federal Trade Commission and the European Commission of the pending $5.3 billion acquisition of Alere by Abbott.

The terms of the Epocal sale were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.